This resource is no longer available
“70% of potential participants live more than two hours from trial sites, so decentralization broadens trial access to reach a larger number and potentially more diverse pool of patients,” writes McKinsey and Company.
This quote teases a few advantages of decentralized clinical trials (DCTs), which accommodate the changing landscape of clinical trials—influenced by patient centricity, new wearable technology, and increasingly personalized medicines.
Hop into minute 6 of this webinar to understand the ins and outs of DCTs, including:
- The benefits of DCTs
- DCT types, considerations, best practices, & impact
- Loftware Prisym 360 overview
- And more